These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8656342)

  • 1. Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.
    Yamada Y; Matsuyama K; Ito K; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1995 Oct; 23(5):463-78. PubMed ID: 8656342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
    Yamada Y; Takayanagi R; Tsuchiya K; Ito K; Ohtani H; Sawada Y; Iga T
    J Ocul Pharmacol Ther; 2001 Jun; 17(3):235-48. PubMed ID: 11436944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Clinical Efficacy and Adverse Effects of β-Blocking Agents Used Clinically for Chronic Heart Failure.
    Takayanagi R; Fujito K; Kimura K; Yamada Y
    Biol Pharm Bull; 2017; 40(6):837-843. PubMed ID: 28566627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of beta 1- and beta 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly.
    Kaila T; Iisalo E; Lehtonen A; Saarimaa H
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):839-49. PubMed ID: 7912102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
    Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
    Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy.
    Yamada Y; Shibuya F; Hamada J; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1995 Apr; 23(2):131-45. PubMed ID: 8719233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of beta-adrenoceptor blocking drugs in hyperthyroidism.
    Feely J; Peden N
    Drugs; 1984 May; 27(5):425-46. PubMed ID: 6144501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betaxolol-induced deterioration of asthma and a pharmacodynamic analysis based on beta-receptor occupancy.
    Miki A; Tanaka Y; Ohtani H; Sawada Y
    Int J Clin Pharmacol Ther; 2003 Aug; 41(8):358-64. PubMed ID: 12940593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
    Svendsen TL; Trap-Jensen J; Carlsen JE; McNair A
    Am Heart J; 1985 May; 109(5 Pt 2):1145-50. PubMed ID: 2859778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clinical bradycardiac effect and respiratory adverse effect of β-blocking agents in coronary computed tomography angiography based on theoretical analysis.
    Fujito K; Takayanagi R; Kimura K; Yokoyama H; Yamada Y
    Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):157-67. PubMed ID: 25510848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta blockers in migraine prophylaxis].
    Shimizu T
    Brain Nerve; 2009 Oct; 61(10):1125-30. PubMed ID: 19882938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers and asthma.
    Decalmer PB; Chatterjee SS; Cruickshank JM; Benson MK; Sterling GM
    Br Heart J; 1978 Feb; 40(2):184-9. PubMed ID: 25075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration and selectivity in beta-adrenoceptor blocking action of a beta-adrenoceptor blocking drug, D-32 in conscious dogs.
    Himori N; Honma S; Izumi A; Ishimori T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Feb; 316(1):19-23. PubMed ID: 6116195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of acebutolol, atenolol, and metoprolol in healthy volunteers estimated by the extent the drugs occupy beta 2-receptors in the circulating plasma.
    Kaila T; Iisalo E
    J Clin Pharmacol; 1993 Oct; 33(10):959-66. PubMed ID: 8227468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.